Compare Sirius XM Holdings Inc (SIRI) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sirius XM Holdings Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? Sirius XM Holdings Inc trades at $26.42 (market cap $8.94B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.76B). The key difference: Sirius XM Holdings Inc is far larger — about 5.1× Vir Biotechnology Inc. Common Stock's market cap, and Sirius XM Holdings Inc pays a 4.07% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sirius XM Holdings Inc for 103 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| SIRI | VIR | |
|---|---|---|
Market Cap | $8.94B | $1.76B |
Volume | 2,400,454 | 2,764,948 |
Sector | Media | Health |
52-Week High | $32.59 | $11.78 |
52-Week Low | $19.92 | $5.12 |
Typical Hold Time | 103 Days | 0 Days |
Enterprise Value | $18.22B | $1.32B |
Dividend Yield | 4.07% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Sirius XM (SIRI) trades at $26.57, down slightly by 0.15% today, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net income margin of 10.23% for 2025, with revenue of $8.56B, and maintains a dividend payout. Recent news highlights a 53% YTD stock surge and positive analyst upgrades driven by advertising growth and a strategic YouTube partnership.
The outlook is cautiously optimistic, supported by strong analyst buy ratings (62.5%) and a consensus price target of $34.43, implying significant upside. Key risks include recent earnings misses, high debt levels, and competitive pressures in the media sector. Cash flow trends show improvement, with net cash flow turning positive in 2026 projections.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sirius XM Holdings Inc
SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
